Decision Aid for Lentigo Maligna

The Decision Aid for Lentigo Maligna was developed by members of the American Society for Dermatologic Surgery with iterative feedback from patients. It contains evidence-based information regarding LM and various treatment modalities, including surgery, imiquimod 5%, radiation, as well as active surveillance. Treatment-specific information includes treatment efficacy, advantages and adverse effects, expected follow up, and estimated associated costs. The “things I might consider in my decision” section of the decision aid contains questions regarding lifestyle, comorbidities, social factors, and disease-related concerns.恶性雀斑样痣决策辅助工具（Decision Aid for Lentigo Maligna）由美国皮肤病外科医师学会（American Society for Dermatologic Surgery）成员开发，并吸纳了患者的迭代反馈。该工具包含针对恶性雀斑样痣（LM）的循证医学信息，涵盖手术、5%咪喹莫特乳膏、放射治疗以及主动监测等多种治疗手段。针对特定治疗的信息包括治疗有效性、优势与不良反应、预期随访方案以及预估相关费用。该决策辅助工具的「决策考量事项」板块包含了与生活方式、合并症、社会因素以及疾病相关顾虑相关的问题。